The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...

This study came out of a multi-institutional collaboration called the BRCA BCY group, which is an international group of ...

At the San Antonio Breast Cancer Symposium, researchers reported that real-time monitoring with smart pill bottles ...

In a phase III trial, pre-op MRI did not reduce locoregional recurrences or improve survival among women with early-stage ...

GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...

Lumpectomy has been the standard of care for low-risk, early-stage breast cancer, but now cryoablation — freezing cancer ...

The test is now ordered by breast surgeons or radiation oncologists in more than 85% of the top 50 U.S. cancer centers.

A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch ...

The test, developed by Astrin Biosciences, utilizes deep proteomic profiling and a machine learning classifier to identify ...

The U.S. Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab deruxtecan-nxki) in combination with ...

The 5 most-read breast cancer articles on AJMC.com this year included FDA approvals, emerging therapies for metastatic breast ...